OST Enzyme 3D Model for N-Glycosylation Component Design
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack the ability to predict or design components essential for the versatile prokaryotic OST-based N-glycosylation system, and there is a lack of insight into the structural requirements for OST glycosylation inhibitors, which could have significant medical, diagnostic, and scientific value.
Innovation Solution
A three-dimensional X-ray structure of the PglB protein from Campylobacter lari is provided, co-crystallized with the optimal hexapeptide substrate, allowing for the identification and design of oligosaccharide donors, oligosaccharyltransferases, consensus sequence motifs, and glycosylation inhibitors by optimizing stereochemical complementarity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If a three-dimensional model of OST is generated to enable rational design of glycosylation components, then the ability to predict and design oligosaccharide donors, OST variants, consensus sequence motifs, and glycosylation inhibitors is improved, but the complexity of the system and the difficulty of obtaining high-resolution structural data are worsened
Solution Approach 1:
The patent uses a computational model (copy) of the OST enzyme structure to represent the complex biological system. This 3D model captures the essential structural information needed for rational design without requiring direct manipulation of the actual enzyme or its substrates, thereby reducing the complexity of working with the native system.
Solution Approach 2:
The patent employs molecular docking simulations and computational algorithms to systematically vary structural parameters of potential components (oligosaccharide donors, consensus sequences, inhibitors) to optimize their interaction with the OST model. This parameter optimization approach simplifies the design process by transforming complex biological design problems into computational parameter optimization problems.
2Manufacturing precision
If high-resolution crystal structures of OST are obtained to understand the reaction mechanism, then the design precision of glycosylation components is improved, but the difficulty of obtaining such structures due to low abundance and insolubility of LLO substrates is worsened
Solution Approach 1:
The patent introduces computational models and molecular docking simulations as intermediary tools between the unavailable high-resolution crystal structures and the design requirements. These computational intermediaries allow prediction and optimization of component structures without requiring actual crystallographic data, overcoming the limitation of substrate insolubility and low abundance.
Solution Approach 2:
The patent replaces the mechanical/crystallographic approach (X-ray crystallography) with computational modeling and molecular simulation methods. This substitution allows access to structural information without the experimental difficulties of crystallizing membrane-bound enzymes and their lipid-linked oligosaccharide substrates, thereby achieving design precision without the measurement difficulties.
3Productivity
If the OST enzyme is used to transfer oligosaccharides to recombinant proteins, then the productivity of glycosylated protein production is improved, but the lack of understanding of substrate specificity and catalytic mechanism limits the versatility of the system
Solution Approach 1:
The patent employs dynamic molecular docking simulations and computational algorithms to predict how different oligosaccharide donors, consensus sequence motifs, and inhibitors interact with the OST enzyme. This dynamic computational approach allows the system to be adapted to different substrates and conditions, enhancing versatility while maintaining high productivity through rational design of optimized components.
Data Source
AI summary
The present invention is directed to methods for identifying or designing (a) a potential oligosaccharide donor, (b) a potential oligosaccharyltransferase (OST), (c) a potential consensus sequence motif polypeptide, and/or (d) a potential glycosylation inhibitor for use in the oligosaccharyltransferase (OST)—catalysed asparagine-linked (“N-linked”) glycosylation, comprising the steps of generating a three-dimensional model of the catalytic domain and/or the polypeptide binding site of the oligosaccharyltransferase (OST) of Campylobacter lari, and designing or selecting a potential component selected from (a) to (d) which optimizes the stereo chemical complementarity of said three-dimensional model(s) and the potential component.